Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.
about
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinomaImaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRICryoablation Versus Radiofrequency Ablation for Hepatic Malignancies: A Systematic Review and Literature-Based AnalysisThe role of interventional radiology in the management of hepatocellular carcinomaTherapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signalingMR imaging-histopathologic correlation of radiofrequency thermal ablation lesion in a rabbit liver model: observation during acute and chronic stagesPercutaneous radio frequency ablation of small renal tumors: initial resultsRadiofrequence ablation of liver cancers.Real-time monitoring of radiofrequency ablation and postablation assessment: accuracy of contrast-enhanced US in experimental rat liver modelRole of local ablative therapy for hepatocellular carcinomaRecent advances in radiofrequency ablation for the management of hepatocellular carcinoma.Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinomaMinimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Review article: percutaneous treatment of hepatocellular carcinoma.Image-guided tumor ablation: standardization of terminology and reporting criteriaThe imprint of radiofrequency in the management of hepatocellular carcinomaThrombocytopenia represents a risk for deterioration of liver function after radiofrequency ablation in patients with hepatocellular carcinomaCurrent management of hepatocellular carcinoma.Mesohepatectomy for the treatment of patients with centrally located hepatocellular carcinoma.Radiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0TProtein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation.Curative effect of stereotactic body radiotherapy on hepatic hilar carcinoma.Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations.Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.Successful treatment of hypovascular advanced hepatocellular carcinoma with lipiodol-targetting intervention radiology.Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma.MR-arterioportography: a new technical approach for detection of liver lesions.Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma.Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy.Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis CRadiofrequency ablation for incidentally identified primary intrahepatic cholangiocarcinomaThe efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization for primary hepatocellular carcinoma in a cohort of 487 patientsManagement of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation era.Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volumeClinical applications of radio-frequency ablation in liver metastasis of colorectal cancer.Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablationRandomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.
P2860
Q24544663-C4077EC8-2102-4CDA-9379-4EA4EAE9D5EDQ26772233-D2FE63BA-4A7F-46B4-965F-CE1CDB6298D0Q26776498-D48E59A2-5BF0-488D-BFC5-7910D5C3E2D7Q26996805-4EB862CC-4142-469D-B447-5556C8BCAB2BQ27016138-13CCB059-5577-499B-885A-FD2A8693F85CQ27318569-C8E6A2D6-74AD-41DF-A739-A565AD3A3CA9Q28344055-7BDC57CC-4B55-4877-81CD-841A83062D26Q28366424-CEA74D94-0D77-463D-B0E2-472B626B0810Q30396930-AFF9C488-39E6-4DAD-89D6-E04C47B09A8EQ30409419-A4B2B35C-2100-46D7-A43E-396E6E0AD824Q30417048-CDDD7F39-1150-407B-8921-3CB8E0738A31Q30460837-D644D283-D5D1-4F02-9AFA-8E62E583D849Q30462664-EA5CDE83-55E6-4096-A6DC-E65A401D1C5AQ30468280-D3EC3FD6-04A0-4C1C-A22A-DA0C4F19AA72Q30942931-A6032FDF-1DEC-4316-8239-71C3DDCCA3F2Q31161842-71FC8664-DD0C-49AD-8EDE-23E60CFB1A2FQ33323289-1420051B-CBEE-4546-A717-B43E612A38ACQ33403977-C2142C57-B31A-4A69-9ECB-121C2590E8B8Q33582165-1BD05D04-6DA6-4816-AEAA-25CA24038A0EQ33932728-596CFBC5-27F5-4933-8444-9D73323C70BEQ34015608-C4C2B23D-8D01-4961-9870-ABFBFAEDE94CQ34045477-D39BC57E-72AD-4C42-85D4-298B6EA10B1DQ34265934-1737919D-E238-4693-B1CB-586E0608282AQ34469509-8A3B4623-443B-4477-86A1-4473E632F05BQ34483032-63611F36-8CFB-4465-B64F-C5F107AB572FQ34532749-D6AE49E1-B93D-4CBB-9260-53DF2CBCA148Q34551964-AC91864B-4822-4C02-8A20-10FFADA37FE9Q34606154-46BB45D1-48FF-4C29-900F-2B7E87065000Q34672331-74EBC1C4-0736-4D55-A496-04E7DF4A7428Q34772055-EAE247C9-FEC9-45E0-97F9-CA4FB673AE76Q35010394-37546AEA-B259-4C19-893A-FF29D822A098Q35010404-DEA1E00B-841E-40FB-84DD-2825C167B3A9Q35010773-C689A2AA-4D7F-44E1-9243-974F24DCB62DQ35059763-FB1A866E-18B6-4797-9AF7-5E5BDE824062Q35106641-117BB6D9-6D0B-4FAA-94F4-F25916BFB008Q35143970-3A7ED11F-C029-454B-8515-F788734402F3Q35231839-63073254-18F5-4827-844A-17EC6F7F3506Q35233514-B79C7D0D-570F-41ED-9A72-5F717C21A253Q35435327-2C92C6F2-E32C-4445-AFE1-F3305CB34BE9Q35598182-8F5D4B30-0521-4FC4-B505-CCC3000BC554
P2860
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.
@en
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.
@nl
type
label
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.
@en
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.
@nl
prefLabel
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.
@en
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.
@nl
P2093
P2860
P1433
P1476
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.
@en
P2093
J Nicolas Vauthey
S A Curley
P2860
P304
P356
10.1097/00000658-200009000-00010
P407
P577
2000-09-01T00:00:00Z